Related Experiment Video
Updated: Sep 21, 2026

Ex Vivo Analysis of Mechanically Activated Ca2+ Transients in Urothelial Cells
Published on: September 28, 2022
Vysis UroVysion for the detection of urothelial carcinoma
1Mayo Clinic and Foundation, Department of Laboratory Medicine and Pathology, Rochester, MN 55905, USA. halling.kevin@mayo.edu
Abstract:
For decades, cystoscopy and urine cytology have been the mainstay for monitoring superficial urothelial carcinoma patients for tumor recurrence. However, urine cytology has poor sensitivity for urothelial carcinoma and, consequently, numerous investigators have been endeavoring to develop more sensitive assays for the detection of urothelial carcinoma. This article presents an overview of the types of new assays that have been developed for urothelial carcinoma detection but focuses primarily on the features and performance of a new fluorescence in situ hybridization assay for urothelial carcinoma detection known as Vysis UroVysion.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urologic Endoscopic Procedure: Cystoscopic Examination
Imaging Studies II: Ultrasonography
Urodynamic Studies: Uroflowmetry
Ureters

